The Catastrophic Antiphospholipid Syndrome

The addition of the word “catastrophic” to the term antiphospholipid syndrome (APS) was proposed 20 years ago by Ronald Asherson when he published an editorial in The Journal of Rheumatology describing a group of patients who develop multiple thrombosis in a short period of time and with a much wors...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Pintó, Ignasi, Espinosa, Gerard, Cervera, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153043/
http://dx.doi.org/10.1007/978-3-319-11044-8_20
_version_ 1783521600934510592
author Rodríguez-Pintó, Ignasi
Espinosa, Gerard
Cervera, Ricard
author_facet Rodríguez-Pintó, Ignasi
Espinosa, Gerard
Cervera, Ricard
author_sort Rodríguez-Pintó, Ignasi
collection PubMed
description The addition of the word “catastrophic” to the term antiphospholipid syndrome (APS) was proposed 20 years ago by Ronald Asherson when he published an editorial in The Journal of Rheumatology describing a group of patients who develop multiple thrombosis in a short period of time and with a much worse prognosis than that attributed to patients with classic APS [1]. Since then, many cases have been published reporting patients with this devastating variant of the APS.
format Online
Article
Text
id pubmed-7153043
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-71530432020-04-13 The Catastrophic Antiphospholipid Syndrome Rodríguez-Pintó, Ignasi Espinosa, Gerard Cervera, Ricard Antiphospholipid Antibody Syndrome Article The addition of the word “catastrophic” to the term antiphospholipid syndrome (APS) was proposed 20 years ago by Ronald Asherson when he published an editorial in The Journal of Rheumatology describing a group of patients who develop multiple thrombosis in a short period of time and with a much worse prognosis than that attributed to patients with classic APS [1]. Since then, many cases have been published reporting patients with this devastating variant of the APS. 2014-11-07 /pmc/articles/PMC7153043/ http://dx.doi.org/10.1007/978-3-319-11044-8_20 Text en © Springer International Publishing Switzerland 2015 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Rodríguez-Pintó, Ignasi
Espinosa, Gerard
Cervera, Ricard
The Catastrophic Antiphospholipid Syndrome
title The Catastrophic Antiphospholipid Syndrome
title_full The Catastrophic Antiphospholipid Syndrome
title_fullStr The Catastrophic Antiphospholipid Syndrome
title_full_unstemmed The Catastrophic Antiphospholipid Syndrome
title_short The Catastrophic Antiphospholipid Syndrome
title_sort catastrophic antiphospholipid syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153043/
http://dx.doi.org/10.1007/978-3-319-11044-8_20
work_keys_str_mv AT rodriguezpintoignasi thecatastrophicantiphospholipidsyndrome
AT espinosagerard thecatastrophicantiphospholipidsyndrome
AT cerveraricard thecatastrophicantiphospholipidsyndrome
AT rodriguezpintoignasi catastrophicantiphospholipidsyndrome
AT espinosagerard catastrophicantiphospholipidsyndrome
AT cerveraricard catastrophicantiphospholipidsyndrome

Ejemplares similares